Imiquimod for the treatment of basal cell or squamous cell carcinoma : a review of clinical effectiveness and cost-effectiveness /
The purpose of this review is to compare the clinical effectiveness and cost-effectiveness of imiquimod (IMQ) to other treatment modalities for the treatment of basal cell carcinoma (BCC) or squamous cell carcinoma (SCC). This report is the first in the series of three reports on IMQ. The following...
Saved in:
| Online Access: |
http://www.ncbi.nlm.nih.gov/books/NBK525601/ Full text |
|---|---|
| Main Authors: | , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Ottawa (ON) :
Canadian Agency for Drugs and Technologies in Health,
2017
|
| Edition: | Version: 1.0. |
| Series: | Rapid response report (Canadian Agency for Drugs and Technologies in Health)
|
| Subjects: |
